Clinical trial
Intranasal Civamide for Episodic Cluster Headache
NCT00069082 · Winston Laboratories, Industry · Completed
Key facts
| NCT number | NCT00069082 |
|---|---|
| Title | Intranasal Civamide for Episodic Cluster Headache |
| Official title | A Phase III, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multicenter Evaluation of Civamide (Zucapsaicin) Nasal Solution in the Treatment of Episodic Cluster Headache |
| Lead sponsor | Winston Laboratories, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Episodic Cluster Headache |
| Intervention type | Drug |
| Interventions | Civamide (Zucapsaicin), Sodium Chloride |
| Enrollment | 2 |
| Start date | Aug 1, 2003 |
| Primary completion | Jan 1, 2004 |
| Completion | Jan 1, 2004 |
| First posted | Sep 16, 2003 |
| Last update posted | Jun 10, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: